SHARE

Loading Events

« All Events

  • This event has passed.

Indian Health & Life Sciences Seminar, House of Lords, 2 November 2011

02.11.2011 @ 11:00 am

Indian Health & Life Sciences Seminar, House of Lords, 2 November, 2011

UK Trade & Investment is holding an India health and life sciences seminar at the House of Lords on Wednesday 2 November followed by a networking reception at the Department for Business, Innovation and Skills.

This seminar is a chance for UK companies to discover the potential business opportunities in the health and life sciences sector in the Indian market.

At this unique event you will hear about the opportunities in India for British companies, as well as the challenges and success stories. Find out the latest information about the Indian economy, the political landscape, cultural considerations and what British companies need to know in order to achieve success in the market.

UK Trade & Investment will offer advice on how we can assist you with our services and meet our network of advisers and experts, based in New Delhi, Kolkata, Bangalore, Chennai, Mumbai, Hyderabad, Pune and Ahmadabad.

Main speakers:

Lord Bilimoria (House of Lords)
Rt Hon Patricia Hewitt (Chair, UK India Business Council)
Mike Nithavrianakis (Deputy High Commissioner, Southern India)
Dr Prithvi Mohandas (MIOT Hospitals, Chennai)
Top Industry Speaker
Further Information:
For further details (including a flyer) please visit the UKTI website.

How to Apply:

This event is open to individuals, companies and organisations who are keen to find out more about the health and life sciences sector in India. Tickets will be allocated on a first come, first served basis and places are limited.

Please register your interest by e-mailing mina.joshi@ukti.gsi.gov.uk or call Tel: +44 (0)207 215 8489 or Mobile: +44 (0)7793874984

Deadline for registration is Monday 30 October 2011.
 

Details

Date:
02.11.2011
Time:
11:00 am
Event Category:

MediWales Supporters:

Subscribe to our Mediwales newsletter

  • This field is for validation purposes and should be left unchanged.